Qsemble Capital Management’s Moderna MRNA Stock Holding History

Qsemble Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,533	Closed	-$370K	–	552
2025 Q4	$370K	Sell	12,533 -62,484	-83%	-$1.7M	0.03%	411
2025 Q3	$1.94M	Buy	75,017 +59,887	+396%	+$1.67M	0.19%	169
2025 Q2	$417K	Buy	+15,130	New	+$398K	0.04%	341
2024 Q2	–	Sell	-11,087	Closed	-$1.18M	–	519
2024 Q1	$1.18M	Buy	+11,087	New	+$1.12M	0.26%	152

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qsemble Capital Management's MRNA Position: Q1 2026 in Review

Qsemble Capital Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 12,533 shares — an estimated $370K sold.

Qsemble Capital Management first reported a position in MRNA in Q1 2024 and held it in 4 quarters. The position peaked at $1.94M in Q3 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Qsemble Capital Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
Qsemble Capital Management sold 12,533 Moderna shares in Q1 2026, an estimated $370K.
Qsemble Capital Management first reported a position in Moderna in Q1 2024 and held it in 4 quarters.
Qsemble Capital Management's Moderna position peaked at $1.94M in Q3 2025.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Qsemble Capital Management's 13F filing for Q1 2026, filed 7 May 2026.